Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 6/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | ALDH5A1 | P51649 | 2/20 | 0.38 |
| ▸ | ABAT | P80404 | 2/20 | 0.38 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.38 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.38 |
| ▸ | TYR | P14679 | 1/20 | 0.37 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | FDPS | P14324 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3376315 | 0.83 | ALDH1A1 (0.48) | ALDH1A1KDM4EPTGS2RAB9ATSHR | |
| SCHEMBL6436517 | 0.83 | ALDH1A1 (0.48) | ALDH1A1KDM4EPTGS2RAB9ATSHR | |
| SCHEMBL1575198 | 0.83 | ALDH1A1 (0.48) | ALDH1A1KDM4EPTGS2RAB9ATSHR | |
| SCHEMBL1576019 | 0.81 | ALDH1A1 (0.47) | ALDH1A1KDM4EPTGS2RAB9ATSHR | |
| SCHEMBL11856373 | 0.81 | KDM4E (0.57) | ALDH1A1KDM4EPTGS2RAB9ATSHR | |
| SCHEMBL19923143 | 0.81 | KDM4E (0.57) | ALDH1A1KDM4EPTGS2RAB9ATSHR | |
| SCHEMBL1575377 | 0.81 | ALDH1A1 (0.57) | ALDH1A1KDM4EPTGS2RAB9ATSHR | |
| SCHEMBL20529249 | 0.81 | ALDH1A1 (0.47) | ALDH1A1KDM4EPTGS2RAB9ATSHR | |
| SCHEMBL7951906 | 0.81 | ALDH1A1 (0.47) | ALDH1A1KDM4EPTGS2RAB9ATSHR | |
| SCHEMBL5760222 | 0.81 | ALDH1A3 (0.47) | ALDH1A1KDM4EPTGS2RAB9ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0035624-A2 | Aldehydes | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1981-09-16 | — | — | EP | claimed |
| EP-0003212-A1 | 2.4-Diamino-5-benzylpyrimidines, pharmaceutical compositions containing them and their preparation | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1979-08-08 | — | — | EP | claimed |
| EP-2252296-A1 | 3H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES | Wyeth LLC (US) | 2010-11-24 | — | — | EP | disclosed |
| WO-2009091788-A1 | 3H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES | WYETH (US) | 2009-07-23 | — | — | WO | disclosed |
| US-20090181963-A1 | 3H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES | WYETH (US) | 2009-07-16 | — | — | US | disclosed |
| US-7381842-B2 | Oxime ester photoinitiators | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2008-06-03 | — | — | US | disclosed |
| US-6949678-B2 | Oxime ester photoinitiators | CIBA SPECIALTY CHEMICALS CORP. (US) | 2005-09-27 | — | — | US | disclosed |
| US-20050191567-A1 | Oxime ester photoinitiators | KUNIMOTO KAZUHIKO (JP) | 2005-09-01 | — | — | US | disclosed |
| US-20010012596-A1 | For resist applications; thermostability, storage stability | CIBA SPECIALTY CHEMICALS CORP. | 2001-08-09 | — | — | US | disclosed |
| EP-0032395-B1 | BENZYLPYRIMIDINES | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1983-03-23 | — | — | EP | disclosed |
| EP-0003212-B1 | 2.4-DIAMINO-5-BENZYLPYRIMIDINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR PREPARATION | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1982-03-17 | — | — | EP | disclosed |
| EP-0035624-A2 | Aldehydes | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1981-09-16 | — | — | EP | disclosed |
| EP-0035624-A2 | Aldehydes | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1981-09-16 | — | — | EP | disclosed |
| EP-0032395-A1 | Benzylpyrimidines | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1981-07-22 | — | — | EP | disclosed |
| EP-0003212-A1 | 2.4-Diamino-5-benzylpyrimidines, pharmaceutical compositions containing them and their preparation | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1979-08-08 | — | — | EP | disclosed |
| EP-0003212-A1 | 2.4-Diamino-5-benzylpyrimidines, pharmaceutical compositions containing them and their preparation | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1979-08-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090181963-A1 | 3H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES | MTOR, PIK3CA, PIK3CD | ALDH1A1 3181/4885KDM4E 1194/4885PTGS2 2942/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.